Yayın:
Pyrazolyl‐Benzoxazinone Derivatives as Dual Hsp Inhibitors in Human Breast Cancer

dc.contributor.authorKani, İbrahim
dc.contributor.authorVolkan Kamaci
dc.contributor.authorCeylan Özsoy
dc.contributor.authorYusuf Sert
dc.contributor.authorİbrahim Kani
dc.contributor.authorLütfi Tutar
dc.contributor.authorYusuf Tutar
dc.contributor.orcid0000-0001-7873-159X
dc.contributor.orcid0000-0001-8836-8667
dc.contributor.orcid0000-0002-7654-6013
dc.contributor.orcid0000-0003-2613-9644
dc.date.accessioned2025-11-13T10:57:41Z
dc.date.issued2022-05-17
dc.identifier.doihttps://doi.org/10.1002/slct.202200359
dc.identifier.issn2365-6549
dc.identifier.issue19
dc.identifier.openalexW4280609947
dc.identifier.urihttps://hdl.handle.net/11421/5789
dc.identifier.urihttps://doi.org/10.1002/slct.202200359
dc.identifier.volume7
dc.language.isoen
dc.relation.ispartofChemistrySelect
dc.rightsrestrictedAccess
dc.subjectHeat shock protein
dc.subjectHsp90
dc.subjectApoptosis
dc.subjectCancer cell
dc.subjectChemistry
dc.subjectCytotoxic T cell
dc.subjectCell
dc.subjectChaperone (clinical)
dc.subjectProtein folding
dc.subjectBiochemistry
dc.subjectCancer research
dc.subjectCell biology
dc.subjectBiology
dc.subjectCancer
dc.subjectMedicine
dc.subjectIn vitro
dc.subject.sdg3
dc.titlePyrazolyl‐Benzoxazinone Derivatives as Dual Hsp Inhibitors in Human Breast Cancer
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5021104813

Dosyalar

Koleksiyonlar